Eribulin as first-line treatment in older patients with advanced breast cancer: A multicenter phase II trial [SAKK 25/14].
暂无分享，去创建一个
U. Hasler-Strub | C. Rochlitz | A. Mueller | T. Ruhstaller | S. Aebi | K. Ribi | K. Zaman | C. Caspar | B. Thuerlimann | A. Trojan | R. Condorelli | A. Hochstrasser | S. Gerber | M. Fehr | D. Baertschi | R. von Moos | Q. Li | S. Greuter | U. Gick | A. Schreiber